Prostaglandin analogs as EP4 receptor antagonists
This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to th...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
26.04.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts. |
---|---|
Bibliography: | Application Number: CN200480008186 |